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MAIN CONCLUSION 
Heterologous pathway for biosynthesis of the stilbene resveratrol was assembled in 
Lactococcus lactis. The strain was further engineered in order to enhance the production 
efficiency. 
INTRODUCTION 
Bacterial hosts for production of bioactive phenolics from berry fruits (BacHBerry) is a 3 year 
project funded by the Seventh Framework Programme (FP7) of the European Union. The 
overall aim of the project is to establish a sustainable and economically-feasible pipeline for 
production of high-value phenolic compounds originating from berries using bacterial 
platforms. The project covers all levels of the discovery and pre-commercialization process, 
from berry collection screening and identification of novel bioactive polyphenols to 
functional characterization of putative biosynthetic pathways and assembly into Gram-
positive cell factories, with further optimization of extraction methods and production scale-
up by fermentation up to demonstration scale. Within the project DTU fulfills the task of 
constructing polyphenol-producing bacteria using Lactococcus lactis as a host. 
L. lactis belongs to the group of Lactic Acid Bacteria (LAB), members of which have a broad 
range of applications in food industry, including manufacturing of fermented products. The 
generally-regarded as safe (GRAS) status of this organism, as well as robustness, stress 
tolerance, and genetic accessibility make this species an attractive candidate for production of 
food and pharmaceutical ingredients [1]. 
The polyphenol resveratrol (trans-3,5,4’-hydroxystilbene) is a well-known polyphenol with a 
variety of health-beneficial properties, including a link to the so-called “French paradox” [2]. 
In plants the resveratrol biosynthesis occurs through the general phenylpropanoid pathway 
[2]. The pathway can be shortened by using a tyrosine ammonia-lyase that would produce p-
coumaric acid directly from tyrosine (Fig. 1A). As this heterologous pathway consists of only 
three steps, it presents an interesting test case for accessing feasibility of polyphenol 
production in LAB. Several combinations of TAL, 4CL, and STS enzymes from plant, 
bacterial, and fungal sources were introduced into L. lactis and the outcomes are summarized 
below. 
MATERIALS AND METHODS 
Genes encoding for TAL, 4CL, and STS enzymes from plant, bacterial, and fungal sources 
were cloned into a lactococcal expression vector pNZ8048 under control of the nisin-
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inducible promoter PnisA (Fig. 1B). Cells were grown as static cultures in falcon tubes in 
chemically-defined medium (CDM) supplemented with 1% glucose, and expression of the 
pathway was induced with nisin in the early exponential phase. Resveratrol production was 
assayed by HPLC analysis of culture supernatants. Acetyl-CoA carboxylase (ACC)-encoding 
genes were integrated into the genome of the production strain using the pSEUDO system.  
RESULTS AND DISCUSSION 
Analysis of the phenolic content in culture 
supernatants collected during the stationary 
phase of growth revealed that the 
assembled biosynthetic pathway is 
functional and the best producer strain 
yielded 3.0 ± 0.7 μM of resveratrol and 0.7 
± 0.1 μM of p-coumaric acid (Fig. 1B).  
The intracellular pool of malonyl-CoA is 
frequently indicated as the major bottleneck 
in the bioproduction of polyphenolic 
compounds [3]. In order to test whether this 
is also the case for L. lactis, the production 
strain was treated with cerulenin, an inhibitor of fatty acid synthesis that is known to increase 
malonyl-CoA levels in bacteria. Addition of cerulenin 2 hours post-induction resulted in 
about 4-fold increase of resveratrol production (data not shown), proving that the malonyl-
CoA pool is indeed the limiting factor here. ACC 
catalyze conversion of acetyl-CoA into malonyl-CoA, 
thus over-expression of this enzyme should overcome 
this limitation. Indeed, when ACC genes of plant and 
fungal origins were integrated into the genome of L. 
lactis and co-expressed together with the resveratrol 
pathway, production was increased by about three-
fold. The above findings demonstrate that L. lactis has 
a potential for being a new type of cell factory for 
production of polyphenols, especially combined with its 
capacity to grow on alternative substrates, such as whey. 
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Figure 1. A) Heterologous pathway for resveratrol 
biosynthesis in L. lactis. TAL, tyrosine-ammonia 
lyase; 4CL, p-coumaroyl-CoA ligase; STS, stilbene 
synthase. B) Resveratrol concentration in the best 
producer strain and organization of its biosynthetic 
operon. 
Figure 2. Production of resveratrol in L 
lactis co-expressing different ACCs. 
